Global Closed System Drug Transfer Device Market Size Study, by Type, by Closing Mechanism, by Component, by Technology, by End User, and Regional Forecasts 2022-2032

Description

Global Closed System Drug Transfer Device (CSTD) Market is valued at approximately USD 874.23 million in 2023 and is anticipated to grow with a healthy growth rate of more than 17.32% over the forecast period 2024-2032. Closed System Drug Transfer Devices (CSTDs) play a critical role in mitigating exposure to hazardous drugs during preparation and administration, making them indispensable in modern healthcare settings. CSTDs effectively prevent the escape of hazardous drugs and vapor concentrations outside the system, thus ensuring safety for healthcare professionals and patients. The market's growth can be attributed to the increasing prevalence of chronic diseases, particularly cancer, which necessitates the use of potent and hazardous drugs, thus driving the demand for CSTDs.

The increasing use of hazardous drugs in healthcare settings is driving the demand for the Closed System Drug Transfer Device (CSTD) market. Hazardous drugs, including chemotherapy agents, antiviral drugs, and bioengineered medications, pose significant risks to healthcare workers due to their toxic nature. To mitigate these risks, CSTDs are essential as they prevent the escape of hazardous drug vapors and liquids during preparation, administration, and disposal processes. The growing awareness of occupational safety and stringent regulations by health authorities, such as the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH), have further propelled the adoption of CSTDs. Additionally, the increasing incidence of cancer and other chronic diseases requiring hazardous drug treatments has led to a higher volume of drug handling, thus boosting the demand for CSTDs to ensure a safe working environment for healthcare professionals.

The key region in the Global Closed System Drug Transfer Device (CSTD) Market includes North America, Asia Pacific Europe, Latin America, and Middle East & Africa. In 2023, North American region dominates the CSTD market in terms of revenue, driven by the increasing prevalence of cancer and robust research and development infrastructure. Additionally, Europe showcases substantial growth, propelled by its advanced healthcare industry and prominent research initiatives. The Asia-Pacific region is poised for significant growth, fueled by the increasing number of new vendors and the rising prevalence of chronic diseases. Countries such as China and India are anticipated to play pivotal roles in this growth trajectory.

Major market player included in this report are:

Becton, Dickinson and Company
BRAUN SE
Epic Medical
JMS Co. Ltd
Equashield
ICU Medical, Inc
Yukon Medical
Simplivia Healthcare, Ltd.
Caragen Ltd
Corvida Medical
Baxter International Inc.
Teva Pharmaceutical Industries Ltd.
Pfizer Inc.
Novartis AG
Sanofi S.A.

The detailed segments and sub-segment of the market are explained below:

By Type:

Barrier Type
Filtration Type

By Closing Mechanism:

Push to Turn System
Color-to-Color Alignment System
Leur Lock Systems
Others

By Component:

Vial Access Devices
Syringe Safety Devices
Bag/Infusion Set Devices
Others

By Technology:

Compartmentalize Devices
Diaphragm-based Devices
Air Filtration Devices

By End User:

Hospitals & Clinics
Specialty Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Closed System Drug Transfer Device (CSTD) Market Executive Summary

1.1. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Closing Mechanism
- 1.3.3. By Component
- 1.3.4. By Technology
- 1.3.5. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Closed System Drug Transfer Device (CSTD) Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Closed System Drug Transfer Device (CSTD) Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Use of Hazardous Drugs
- 3.1.2. Growing Oncology Services
3.2. Market Challenges
- 3.2.1. High Cost of CSTDs
- 3.2.2. Limited Awareness in Emerging Markets
3.3. Market Opportunities
- 3.3.1. Technological Advancements in CSTDs
- 3.3.2. Expansion in Home Healthcare Services
- 3.3.3. Growing Geriatric Population

Chapter 4. Global Closed System Drug Transfer Device (CSTD) Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Closed System Drug Transfer Device (CSTD) Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Barrier Type
- 5.2.2. Filtration Type

Chapter 6. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Closing Mechanism 2022-2032

6.1. Segment Dashboard
6.2. Global Closed System Drug Transfer Device (CSTD) Market: Closing Mechanism Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Push to Turn System
- 6.2.2. Color-to-Color Alignment System
- 6.2.3. Leur Lock Systems
- 6.2.4. Others

Chapter 7. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Component 2022-2032

7.1. Segment Dashboard
7.2. Global Closed System Drug Transfer Device (CSTD) Market: Component Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Vial Access Devices
- 7.2.2. Syringe Safety Devices
- 7.2.3. Bag/Infusion Set Devices
- 7.2.4. Others

Chapter 8. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Technology 2022-2032

8.1. Segment Dashboard
8.2. Global Closed System Drug Transfer Device (CSTD) Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 8.2.1. Compartmentalize Devices
- 8.2.2. Diaphragm-based Devices
- 8.2.3. Air Filtration Devices

Chapter 9. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by End User 2022-2032

9.1. Segment Dashboard
9.2. Global Closed System Drug Transfer Device (CSTD) Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 9.2.1. Hospitals & Clinics
- 9.2.2. Specialty Centers
- 9.2.3. Others

Chapter 10. Global Closed System Drug Transfer Device (CSTD) Market Size & Forecasts by Region 2022-2032

10.1. North America Closed System Drug Transfer Device (CSTD) Market
- 10.1.1. U.S. Closed System Drug Transfer Device (CSTD) Market
  - 10.1.1.1. Type breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Closing Mechanism breakdown size & forecasts, 2022-2032
  - 10.1.1.3. Component breakdown size & forecasts, 2022-2032
  - 10.1.1.4. Technology breakdown size & forecasts, 2022-2032
  - 10.1.1.5. End User breakdown size & forecasts, 2022-2032
- 10.1.2. Canada Closed System Drug Transfer Device (CSTD) Market
10.2. Europe Closed System Drug Transfer Device (CSTD) Market
- 10.2.1. U.K. Closed System Drug Transfer Device (CSTD) Market
- 10.2.2. Germany Closed System Drug Transfer Device (CSTD) Market
- 10.2.3. France Closed System Drug Transfer Device (CSTD) Market
- 10.2.4. Spain Closed System Drug Transfer Device (CSTD) Market
- 10.2.5. Italy Closed System Drug Transfer Device (CSTD) Market
- 10.2.6. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
10.3. Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
- 10.3.1. China Closed System Drug Transfer Device (CSTD) Market
- 10.3.2. India Closed System Drug Transfer Device (CSTD) Market
- 10.3.3. Japan Closed System Drug Transfer Device (CSTD) Market
- 10.3.4. Australia Closed System Drug Transfer Device (CSTD) Market
- 10.3.5. South Korea Closed System Drug Transfer Device (CSTD) Market
- 10.3.6. Rest of Asia Pacific Closed System Drug Transfer Device (CSTD) Market
10.4. Latin America Closed System Drug Transfer Device (CSTD) Market
- 10.4.1. Brazil Closed System Drug Transfer Device (CSTD) Market
- 10.4.2. Mexico Closed System Drug Transfer Device (CSTD) Market
- 10.4.3. Rest of Latin America Closed System Drug Transfer Device (CSTD) Market
10.5. Middle East & Africa Closed System Drug Transfer Device (CSTD) Market
- 10.5.1. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
- 10.5.2. South Africa Closed System Drug Transfer Device (CSTD) Market
- 10.5.3. Rest of Middle East & Africa Closed System Drug Transfer Device (CSTD) Market

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Becton, Dickinson and Company
  - 11.3.1.1. Key Information
  - 11.3.1.2. Overview
  - 11.3.1.3. Financial (Subject to Data Availability)
  - 11.3.1.4. Product Summary
  - 11.3.1.5. Market Strategies
- 11.3.2. BRAUN SE
- 11.3.3. Epic Medical
- 11.3.4. JMS Co. Ltd
- 11.3.5. Equashield
- 11.3.6. ICU Medical, Inc
- 11.3.7. Yukon Medical
- 11.3.8. Simplivia Healthcare, Ltd.
- 11.3.9. Caragen Ltd
- 11.3.10. Corvida Medical
- 11.3.11. Baxter International Inc.
- 11.3.12. Teva Pharmaceutical Industries Ltd.
- 11.3.13. Pfizer Inc.
- 11.3.14. Novartis AG
- 11.3.15. Sanofi S.A.

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes